한국맥널티
Financials
Valuation Metrics
한국맥널티's Market Cap is ₩243B. At end of 2025 it was ₩357B. Ranked #2228 of 2,421 in KR market (top 92%), #1466 of 1,640 on KOSDAQ (top 89%), #77 of 84 in Food, Beverage & Tobacco (top 92%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 24.32B KRW | KR#2,228/2,421 Sec#77/84 |
| Revenue | 97.26B KRW | KR#1,432/2,421 Sec#66/84 |
| Net Income | -784.8M KRW | KR—/2,421 Sec—/84 |
| Total Assets | 103.10B KRW | KR#1,752/2,421 Sec#72/84 |
| Net Assets | 46.11B KRW | KR#1,961/2,421 Sec#71/84 |
| Employees | 114 | KR#1,542/2,421 Sec#61/84 |
| Value | ||
| P/B | 0.53x | KR#853/2,421 Sec#51/84 |
| P/S | 0.25x | KR#477/2,421 Sec#42/84 |
| FCF Yield | 20.56% | KR#297/2,421 Sec#30/84 |
| Profitability | ||
| ROE | -1.70% | KR#1,666/2,421 Sec#56/84 |
| ROA | -0.76% | KR#1,644/2,421 Sec#56/84 |
| Op. Margin | -1.25% | KR#1,701/2,421 Sec#75/84 |
| Revenue Growth | 3.89% | KR#1,271/2,421 Sec#36/84 |
| Financial Health | ||
| Debt Ratio | 123.58% | KR#1,741/2,421 Sec#45/84 |
| Total Debt | 42.12B KRW | KR#1,068/2,421 Sec#57/84 |
| FCF | 5.00B KRW | KR#909/2,421 Sec#49/84 |
| Cash | 6.32B KRW | KR#1,915/2,421 Sec#71/84 |
| Current Ratio | 1.33x | KR#1,348/2,421 Sec#34/84 |
| Dividend | ||
| Div. Yield | 0.63% | KR#1,225/2,421 Sec#61/84 |
| Div. Growth | 0.00% | KR—/2,421 Sec—/84 |
| Performance | ||
| 1Y Return | -41.90% | KR#1,882/2,421 Sec#75/84 |
| 1M Return | 1.15% | KR#1,098/2,421 Sec#30/84 |
| From 52W High | -48.96% | KR#1,342/2,421 Sec#66/84 |
| 1Y MDD | -55.60% | KR#1,240/2,421 Sec#70/84 |
| Trading | ||
| Volume | 1,901 shares | KR#2,278/2,421 Sec#75/84 |
| Trading Value | 4.2M KRW | KR#2,342/2,421 Sec#81/84 |
| Foreign Own. | 1.82% | KR#1,694/2,421 Sec#62/84 |
| Per Share | ||
| EPS | -71 KRW | KR—/2,421 Sec—/84 |
| BPS | 4,180 KRW | KR#1,628/2,421 Sec#64/84 |
Company Info
Korea McNulty, established in 1997 and headquartered in Cheonan, Chungcheongnam-do, primarily engages in coffee manufacturing and processing. In 2020, it spun off its pharmaceutical business, establishing McNulty Pharm Co., Ltd. and McNulty Bio Co., Ltd. as affiliates. The company's coffee division covers the entire process from green beans to roasted coffee products, while its pharmaceutical division produces general and specialized pharmaceuticals, alongside CMO and CSO services. Korea McNulty is expanding its business by entering large distribution channels, increasing B2B sales, launching a coffee academy, and pursuing the conversion of its Chinese sales subsidiary.